Last 12 months
Inside the activity.
2 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Rowe Robert ScottDirector · President & CEO
|
Exercise / conversionPerformance Rights · Derivative | 67,414 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · derivative · entry 5 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,162 Underlying: Common Stock · 67,414 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period. F4 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period. F4 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 50,456 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · derivative · entry 4 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,843 Underlying: Common Stock · 50,456 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. F3 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. F3 · derivative.underlying: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantPerformance Rights · Derivative | 61,669 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · derivative · entry 3 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,576 Underlying: Common Stock · 61,669 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Rowe Robert ScottDirector · President & CEO
|
Tax withholdingCommon Stock | 28,328 | $62.00 | $1,756,336.00 |
DisclosureSEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · nonDerivative · entry 2 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 393,389 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Rowe Robert ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 71,995 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · nonDerivative · entry 1 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 421,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 210 shares of the issuer's common stock acquired under the Flowserve Employee Stock Purchase Plan in monthly transactions that were exempt under Rule 16b-3. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Wilson KirkPresident, FCD
|
Exercise / conversionPerformance Rights · Derivative | 7,035 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · derivative · entry 5 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,746 Underlying: Common Stock · 7,035 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period. F4 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period. F4 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Wilson KirkPresident, FCD
|
GrantRestricted Stock Units · Derivative | 5,606 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · derivative · entry 4 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,028 Underlying: Common Stock · 5,606 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. F3 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Wilson KirkPresident, FCD
|
GrantPerformance Rights · Derivative | 5,606 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · derivative · entry 3 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,781 Underlying: Common Stock · 5,606 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Wilson KirkPresident, FCD
|
Tax withholdingCommon Stock | 2,964 | $62.00 | $183,768.00 |
DisclosureSEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · nonDerivative · entry 2 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,424 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:29 UTC |
Wilson KirkPresident, FCD
|
Exercise / conversionCommon Stock | 7,513 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · nonDerivative · entry 1 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 43 shares of the issuer's common stock acquired under the Flowserve Employee Stock Purchase Plan in monthly transactions that were exempt under Rule 16b-3. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:28 UTC |
Boukalik BrianChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 5,205 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000010 · wk-form4_1739914122.xml · derivative · entry 2 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,030 Underlying: Common Stock · 5,205 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:28 UTC |
Boukalik BrianChief Human Resources Officer
|
GrantPerformance Rights · Derivative | 5,205 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000010 · wk-form4_1739914122.xml · derivative · entry 1 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,986 Underlying: Common Stock · 5,205 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:28 UTC |
VOPNI SCOTT KChief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 3,569 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000009 · wk-form4_1739914111.xml · derivative · entry 2 VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,714 Underlying: Common Stock · 3,569 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:28 UTC |
VOPNI SCOTT KChief Accounting Officer
|
GrantPerformance Rights · Derivative | 1,529 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-25-000009 · wk-form4_1739914111.xml · derivative · entry 1 VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,845 Underlying: Common Stock · 1,529 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. Read SEC document |
| February 03, 2025 Filed Nov 3, 2025 23:06 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantCommon Stock | 102 | $62.62 | $6,387.24 |
DisclosureSEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 3 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,925 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| February 03, 2025 Filed Nov 3, 2025 22:59 UTC |
Wilson KirkFormer President, FCD
|
GrantCommon Stock | 21 | $62.62 | $1,315.02 |
DisclosureSEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 3 Wilson Kirk · CIK 0001654776 · Former President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,180 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| January 02, 2025 Filed Nov 3, 2025 23:06 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantCommon Stock | 74 | $57.52 | $4,256.48 |
DisclosureSEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 2 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,823 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| January 02, 2025 Filed Nov 3, 2025 22:59 UTC |
Wilson KirkFormer President, FCD
|
GrantCommon Stock | 15 | $57.52 | $862.80 |
DisclosureSEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 2 Wilson Kirk · CIK 0001654776 · Former President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,159 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| December 02, 2024 Filed Nov 3, 2025 23:06 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantCommon Stock | 34 | $61.02 | $2,074.68 |
DisclosureSEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 1 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,749 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| December 02, 2024 Filed Nov 3, 2025 22:59 UTC |
Wilson KirkFormer President, FCD
|
GrantCommon Stock | 7 | $61.02 | $427.14 |
DisclosureSEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 1 Wilson Kirk · CIK 0001654776 · Former President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,144 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:14 UTC |
DELLY GAYLA JDirector
|
GiftCommon Stock | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-24-000102 · wk-form4_1731446080.xml · nonDerivative · entry 1 DELLY GAYLA J · CIK 0001218358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,897 F1 · shares: On November 11, 2024, the reporting person made a charitable gift of 1,700 shares of Common Stock. No shares were sold. Read SEC document |
| November 06, 2024 Filed Nov 6, 2024 22:18 UTC |
SIEGEL KENNETH IDirector
|
GrantPhantom Stock · Derivative | 509 | $59.24 | $30,153.16 |
DisclosureSEC source: 0000030625-24-000100 · wk-form4_1730931506.xml · derivative · entry 1 SIEGEL KENNETH I · CIK 0001465558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,238 Underlying: Common Stock · 509 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| November 06, 2024 Filed Nov 6, 2024 22:18 UTC |
Taylor Carlyn R.Director
|
GrantPhantom Stock · Derivative | 509 | $59.24 | $30,153.16 |
DisclosureSEC source: 0000030625-24-000099 · wk-form4_1730931496.xml · derivative · entry 1 Taylor Carlyn R. · CIK 0001821412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,626 Underlying: Common Stock · 509 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| November 06, 2024 Filed Nov 6, 2024 22:18 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 103 | $59.24 | $6,101.72 |
DisclosureSEC source: 0000030625-24-000098 · wk-form4_1730931485.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,594 Underlying: Common Stock · 103 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| November 06, 2024 Filed Nov 6, 2024 22:18 UTC |
Johnson Cheryl HDirector
|
GrantPhantom Stock · Derivative | 509 | $59.24 | $30,153.16 |
DisclosureSEC source: 0000030625-24-000097 · wk-form4_1730931474.xml · derivative · entry 1 Johnson Cheryl H · CIK 0001552649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,626 Underlying: Common Stock · 509 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 20:12 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 124 | $49.04 | $6,080.96 |
DisclosureSEC source: 0000030625-24-000089 · wk-form4_1722543112.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,491 Underlying: Common Stock · 124 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 20:11 UTC |
Johnson Cheryl HDirector
|
GrantPhantom Stock · Derivative | 615 | $49.04 | $30,159.60 |
DisclosureSEC source: 0000030625-24-000088 · wk-form4_1722543101.xml · derivative · entry 1 Johnson Cheryl H · CIK 0001552649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,117 Underlying: Common Stock · 615 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 20:11 UTC |
SIEGEL KENNETH IDirector
|
GrantPhantom Stock · Derivative | 615 | $49.04 | $30,159.60 |
DisclosureSEC source: 0000030625-24-000087 · wk-form4_1722543091.xml · derivative · entry 1 SIEGEL KENNETH I · CIK 0001465558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,729 Underlying: Common Stock · 615 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 20:11 UTC |
Taylor Carlyn R.Director
|
GrantPhantom Stock · Derivative | 615 | $49.04 | $30,159.60 |
DisclosureSEC source: 0000030625-24-000086 · wk-form4_1722543080.xml · derivative · entry 1 Taylor Carlyn R. · CIK 0001821412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,117 Underlying: Common Stock · 615 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 28, 2024 Filed May 29, 2024 20:16 UTC |
Boukalik BrianChief Human Resources Officer
|
GrantPerformance Rights · Derivative | 3,781 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-24-000078 · wk-form4_1717013786.xml · derivative · entry 3 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,781 Underlying: Common Stock · 3,781 shares Expires not disclosed F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2024 and ending on December 31, 2026 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F3 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2024 and ending on December 31, 2026 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. F3 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2024 and ending on December 31, 2026 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. Read SEC document |
| May 28, 2024 Filed May 29, 2024 20:16 UTC |
Boukalik BrianChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 3,781 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-24-000078 · wk-form4_1717013786.xml · derivative · entry 2 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,825 Underlying: Common Stock · 3,781 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on March 1, 2025. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on March 1, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on March 1, 2025. Read SEC document |
| May 28, 2024 Filed May 29, 2024 20:16 UTC |
Boukalik BrianChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 2,044 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-24-000078 · wk-form4_1717013786.xml · derivative · entry 1 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,044 Underlying: Common Stock · 2,044 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025. Read SEC document |
| May 23, 2024 Filed May 23, 2024 21:53 UTC |
Rowe Robert ScottDirector · President & CEO
|
SaleCommon Stock | 40,182 | $49.36 | $1,983,383.52 |
DisclosureSEC source: 0000030625-24-000074 · wk-form4_1716501182.xml · nonDerivative · entry 3 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,512 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.04 to $50.04, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 23, 2024 Filed May 23, 2024 21:53 UTC |
Rowe Robert ScottDirector · President & CEO
|
SaleCommon Stock | 17,549 | $48.96 | $859,199.04 |
DisclosureSEC source: 0000030625-24-000074 · wk-form4_1716501182.xml · nonDerivative · entry 2 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,694 F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.76 to $49.04, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:51 UTC |
Hudson Susan ClaireChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-24-000076 · wk-form4_1716583884.xml · derivative · entry 3 Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,928 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:51 UTC |
Hudson Susan ClaireChief Legal Officer
|
Tax withholdingCommon Stock | 255 | $48.86 | $12,459.30 |
DisclosureSEC source: 0000030625-24-000076 · wk-form4_1716583884.xml · nonDerivative · entry 2 Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,205 Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:51 UTC |
Hudson Susan ClaireChief Legal Officer
|
Exercise / conversionCommon Stock | 737 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-24-000076 · wk-form4_1716583884.xml · nonDerivative · entry 1 Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:53 UTC |
Rowe Robert ScottDirector · President & CEO
|
SaleCommon Stock | 42,269 | $49.98 | $2,112,604.62 |
DisclosureSEC source: 0000030625-24-000074 · wk-form4_1716501182.xml · nonDerivative · entry 1 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 407,243 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.75 to $50.46, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:11 UTC |
Johnson Cheryl HDirector
|
GrantPhantom Stock · Derivative | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000068 · wk-form4_1715976679.xml · derivative · entry 1 Johnson Cheryl H · CIK 0001552649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,502 Underlying: Common Stock · 3,210 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:12 UTC |
SIEGEL KENNETH IDirector
|
GrantPhantom Stock · Derivative | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000069 · wk-form4_1715976702.xml · derivative · entry 1 SIEGEL KENNETH I · CIK 0001465558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,114 Underlying: Common Stock · 3,210 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:11 UTC |
DELLY GAYLA JDirector
|
GrantCommon Stock | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000067 · wk-form4_1715976656.xml · nonDerivative · entry 1 DELLY GAYLA J · CIK 0001218358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,597 F1 · shares: Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on May 16, 2025. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:10 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000066 · wk-form4_1715976641.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,367 Underlying: Common Stock · 3,210 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:10 UTC |
Roberts David E JrDirector
|
GrantPhantom Stock · Derivative | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000064 · wk-form4_1715976590.xml · derivative · entry 1 Roberts David E Jr · CIK 0001363218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,283 Underlying: Common Stock · 3,210 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:09 UTC |
Taylor Carlyn R.Director
|
GrantPhantom Stock · Derivative | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000063 · wk-form4_1715976562.xml · derivative · entry 1 Taylor Carlyn R. · CIK 0001821412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,502 Underlying: Common Stock · 3,210 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:10 UTC |
McMurray Michael C.Director
|
GrantCommon Stock | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000065 · wk-form4_1715976612.xml · nonDerivative · entry 1 McMurray Michael C. · CIK 0001556386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,663 F1 · shares: Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on May 16, 2025. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:09 UTC |
Chand SujeetDirector
|
GrantPhantom Stock · Derivative | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000062 · wk-form4_1715976516.xml · derivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,754 Underlying: Common Stock · 3,210 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:08 UTC |
Okray Thomas BDirector
|
GrantCommon Stock | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000061 · wk-form4_1715976498.xml · nonDerivative · entry 1 Okray Thomas B · CIK 0001689107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,663 F1 · shares: Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on May 16, 2025. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:08 UTC |
GARRISON JOHN L JRDirector
|
GrantPhantom Stock · Derivative | 3,210 | $49.84 | $159,986.40 |
DisclosureSEC source: 0000030625-24-000060 · wk-form4_1715976460.xml · derivative · entry 1 GARRISON JOHN L JR · CIK 0001656422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,065 Underlying: Common Stock · 3,210 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:41 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 124 | $47.10 | $5,840.40 |
DisclosureSEC source: 0000030625-24-000049 · wk-form4_1714682497.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,157 Underlying: Common Stock · 124 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:41 UTC |
SIEGEL KENNETH IDirector
|
GrantPhantom Stock · Derivative | 610 | $47.10 | $28,731.00 |
DisclosureSEC source: 0000030625-24-000048 · wk-form4_1714682482.xml · derivative · entry 1 SIEGEL KENNETH I · CIK 0001465558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,904 Underlying: Common Stock · 610 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.